# Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited

> **NCT03320811** · — · COMPLETED · sponsor: **CHU de Reims** · enrollment: 2026 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **OTHER:** Data record

## Key facts

- **NCT ID:** NCT03320811
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2015-09-01
- **Final completion:** 2016-01-01
- **Target enrollment:** 2026 (ACTUAL)
- **Last updated:** 2017-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03320811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03320811, "Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03320811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*